← Browse by Condition
Medical Condition

end stage renal disease

Total Trials
5
Recruiting Now
5
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for end stage renal disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — end stage renal disease Clinical Trials

How many clinical trials are currently recruiting for end stage renal disease?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for end stage renal disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for end stage renal disease?
end stage renal disease research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a end stage renal disease clinical trial?
Eligibility criteria for end stage renal disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1 trial
Massachusetts General Hospital 1 trial
Assistance Publique Hopitaux De Marseille 1 trial
Johns Hopkins University 1 trial
Indiana University 1 trial

Recruiting Clinical Trials

NCT05917795
Recruiting

Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates

Enrollment
24 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
View Trial →
NCT03032835
Recruiting

Partners Calciphylaxis Biobank

Enrollment
300 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT06224140
Recruiting

Heparin-Free Chronic HemoDialysis Assessment

Enrollment
100 pts
Location
France
Sponsor
Assistance Publique Hopitaux D...
View Trial →
NCT03803423
Recruiting

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

Enrollment
1,000 pts
Location
United States
Sponsor
Johns Hopkins University
View Trial →
NCT07360938
Recruiting

Drug Interaction Potential of Pro-Inflammatory Conditions

Enrollment
150 pts
Location
United States
Sponsor
Indiana University
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology